ARTICLE | Clinical News
Elobixibat: Phase III data
October 10, 2016 7:00 AM UTC
Top-line data from a double-blind, Japanese Phase III trial in patients with chronic constipation showed that elobixibat for 14 days met the primary endpoint of improving the number of weekly SBMs fro...